Gastroenterology and liver  Conference 2021 welcomes the multidisciplinary medical professionals, clinicians, and researchers associated with the diagnosis, treatment associated with the diagnosis, treatment and management of gallbladder pancreas and liver diseases and allied fields. This Gastroenterolgy  Congress is the best platform that would help the Hepatologist and a Gastroenterologist to get the insights and latest trends to improve the patients care. All the researchers working in the field of  Achalasia  Barrett’s Esophagus Esophageal Cancer Stomach (Gastric) Cancer Gastroesophageal Reflux Disease (GERD) Gastroparesis Peptic Ulcer Disease Swallowing Disorder   Alcoholic Liver Disease Hepatocellular Carcinoma (Liver Cancer) Liver Transplant Workup  Portal Hypertension Viral Hepatitis A & E Viral Hepatitis B Viral Hepatitis C  and other allied fields will be of interest. The Scope of this Gastroenterology and liver Conference is for the below professionals, but not limited to:

• Researchers
• Scientists
• Health care experts
•  Hepatologist 
• Gastroenterologist
• Cardiologists
• Nephrologists
• Nutritionists/Dieticians
• gastroenterology  Health Professionals
• Physicians
• Nurse practitioners
• Health care analysts
• Doctors
• Academic researchers
• Professors
• Students
• Research Institutes
• Business delegates
• Young Researchers
• Advertising and Promotion Agency Executives
• Professionals in media sector
• Medical colleges
• gastroenterology  Societies & Associations
• liver  Societies & Associations
• Heart Societies & Associations
• Medical & Pharmaceutical Companies
• Medical devices & companies

The global gastrointestinal therapeutics market is expected to reach 13.8 billion USD by 2020. This growth in market is attributed to numerous factors including development of novel therapies using innovative technologies, increasing consumption of biologics, improved diagnostic tools etc.

Increase in the Gastric surgeries across the globe will also directly show impact on the increasing Gastroparesis drug market. Due to primary growth factor, for Global Gastroparesis drug market will increase 940 million USD between 2016-2021 exceeding 7.1 billion USD in market size by the end of the forecast period.

According to the report, the North America region is expected to hold the largest share in the global gastrointestinal diseases market. This dominance of North America is attributed to the rising approval of the novel drugs and the growth in the instances of various gastrointestinal diseases.

The Global Gastrointestinal Endoscopy Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth visions over the coming years. Gastroenterology device market is expected to expand at a CAGR of 7.1% from 2018 – 2026. Over a decade Gastroenterology device market has undergone technical revolution which resulted in increase in laparoscopic surgeries. Global healthcare authorities have adopted three divided procedures to treat gastrointestinal disorder which are limited spread of infection, early medical intervention and rapid diagnosis, Demographic shift, consumption of tobacco, alcohol, fast food and sedentary lifestyle have a positive impact on the gastroenterology devices market. The limitations associated with the market are deficiency of trained professionals and cross contamination associated with frequent use of endoscopic devices.

The latest trend in advance technology in video scopes and capsule endoscopes have gained immense popularity to detect the exact place of GIT damages and taking pictures to rectify and also helpful in conducting minimally invasive surgical procedures. Technically many devices like Gastric enteral feeding devices, Ostomy Products and Bariatric surgery devices will garner growth during the forecast period during 2018 – 2026.  In this case North America is currently topped in geometrical segment for gastroenterology device market

According to the report, one of the major drivers for this market is presence of large patient pool with GI disorders fuelling the market growth. Due to the large patient pool with GI disorders is determining the expected market growth. The growing incidence of GI disorders such as colorectal, oesophageal, or pancreatic cancers, biliary disease, inflammatory bowel disease, and the changes in lifestyle such as an increase in unhealthy diet and physical inactivity resulted in several complications such as raised blood pressure, blood glucose, lipids, and obesity